Design of Functional Nanoparticles for Intractable Disease Therapy

Area of Science:

• Biomaterials Science
• Polymer Chemistry
• Nanotechnology

Background:

• Protein affinity reagents, primarily antibodies, are crucial in research, diagnostics, and therapy.
• Antibody drugs are increasingly used for diseases like cancer due to their specific binding.
• Synthetic polymers offer a cost-effective alternative by mimicking protein-protein interactions.

Purpose of the Study:

• To review the design of synthetic polymer nanoparticles (NPs) for targeting molecules in disease therapy.
• To highlight the development of NPs that bind target peptides and proteins.
• To discuss the potential of these synthetic reagents as abiotic protein affinity reagents.

Main Methods:

• Development of synthetic polymer nanoparticles incorporating charged and hydrophobic monomers.
• Design of polymers to mimic protein-protein interactions for target binding.
• Modification of linear polymers on lipid nanoparticle surfaces for improved biodistribution.

Main Results:

• Synthetic polymer NPs demonstrate nanomolar affinity for target molecules.
• Successful in vitro and in vivo neutralization of toxic peptides and signaling proteins.
• Improved polymer biodistribution achieved through surface modification on lipid nanoparticles.

Conclusions:

• Synthetic polymer NPs represent a promising class of abiotic protein affinity reagents.
• These NPs can effectively neutralize disease-related targets, offering therapeutic potential.
• Further development could lead to cost-effective and versatile therapeutic agents.